LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

Sept 23 (Reuters) - U.S. drug distributor McKesson on Tuesday raised its annual profit forecast to range of $38.05 to $38.55 from its prior expectation of per-share profit being in the range of $37.10 to $37.90. (Reporting by Mrinalika Roy in Bengaluru) ...

08:07 AM EDT, 09/23/2025 (MT Newswires) -- Microbix Biosystems ( MBXBF ) Tuesday said a program to support rapid accurate identification of patients who carry gene-variants that may impede the effectiveness of an antiplatelet (anti-clotting) drug Clopidogrel is now live. This external quality assessment (EQA) program is to help ensure the proficiency of sites performing point-of-care tests. Over 20% of...

08:09 AM EDT, 09/23/2025 (MT Newswires) -- Sempra ( SRE ) said Tuesday it agreed to sell a 45% equity interest in Sempra Infrastructure Partners to affiliates of KKR (KKR) for $10 billion in cash. The $10 billion transaction implies a $22.2 billion equity value as well as a $31.7 billion enterprise value for Sempra Infrastructure Partners, the energy infrastructure...